T2 Biosystems Return on Tangible Equity 2013-2023 | TTOO

Current and historical return on tangible equity values for T2 Biosystems (TTOO) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
T2 Biosystems Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $-0.05B $-0.03B 147.37%
2023-09-30 $-0.05B $-0.02B 135.17%
2023-06-30 $-0.05B $-0.04B 132.48%
2023-03-31 $-0.06B $-0.05B 161.01%
2022-12-31 $-0.06B $-0.04B 183.70%
2022-09-30 $-0.06B $-0.03B 237.04%
2022-06-30 $-0.06B $-0.04B 303.80%
2022-03-31 $-0.05B $-0.03B 675.00%
2021-12-31 $-0.05B $-0.01B 2800.00%
2021-09-30 $-0.05B $-0.00B -1253.33%
2021-06-30 $-0.04B $0.01B -502.86%
2021-03-31 $-0.04B $-0.00B -781.82%
2020-12-31 $-0.05B $0.01B -1253.33%
2020-09-30 $-0.05B $0.02B 728.57%
2020-06-30 $-0.05B $-0.00B 300.00%
2020-03-31 $-0.06B $-0.01B 280.95%
2019-12-31 $-0.06B $-0.03B 302.56%
2019-09-30 $-0.06B $-0.03B 727.27%
2019-06-30 $-0.06B $-0.02B -1341.18%
2019-03-31 $-0.05B $-0.00B -326.15%
2018-12-31 $-0.05B $0.01B -357.89%
2018-09-30 $-0.05B $0.02B -459.57%
2018-06-30 $-0.06B $0.03B -556.10%
2018-03-31 $-0.06B $-0.01B -1142.86%
2017-12-31 $-0.06B $0.00B -435.09%
2017-09-30 $-0.06B $0.02B -248.42%
2017-06-30 $-0.06B $0.01B -181.25%
2017-03-31 $-0.06B $0.03B -164.03%
2016-12-31 $-0.06B $0.04B -148.65%
2016-09-30 $-0.05B $0.05B -133.33%
2016-06-30 $-0.05B $0.02B -158.14%
2016-03-31 $-0.05B $0.04B -137.14%
2015-12-31 $-0.05B $0.05B -124.32%
2015-09-30 $-0.04B $0.02B -111.69%
2015-06-30 $-0.04B $0.03B -83.77%
2015-03-31 $-0.04B $0.04B -91.02%
2014-12-31 $-0.04B $0.05B -102.13%
2014-09-30 $-0.03B $0.06B -118.92%
2014-06-30 $-0.03B $0.01B -248.00%
2014-03-31 $-0.03B $0.02B -290.00%
2013-12-31 $-0.03B $0.02B -452.17%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.017B $0.007B
T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets. It operates primarily in the United States. T2 Biosystems, Inc. is headquartered in Lexington, Massachusetts.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $215.756B 26.24
Intuitive Surgical (ISRG) United States $136.392B 85.13
Edwards Lifesciences (EW) United States $54.342B 35.97
DexCom (DXCM) United States $52.484B 90.16
IQVIA Holdings (IQV) United States $42.513B 25.21
IDEXX Laboratories (IDXX) United States $41.343B 49.43
Alcon (ALC) Switzerland $40.079B 29.56
STERIS (STE) Ireland $20.158B 23.86
Waters (WAT) United States $19.102B 27.46
Hologic (HOLX) United States $18.152B 20.03
SONOVA HOLDING (SONVY) Switzerland $16.645B 0.00
ShockWave Medical (SWAV) United States $12.255B 84.68
Fresenius Medical Care AG KGaA (FMS) Germany $10.792B 13.33
Teleflex (TFX) United States $10.100B 15.86
Sysmex ADR (SSMXY) Japan $10.075B 31.60
Penumbra (PEN) United States $8.416B 104.04
Masimo (MASI) United States $7.298B 40.93
Globus Medical (GMED) United States $6.995B 22.18
Glaukos (GKOS) United States $4.859B 0.00
Integer Holdings (ITGR) United States $3.879B 24.79
TransMedics (TMDX) United States $3.004B 0.00
LivaNova (LIVN) United Kingdom $2.859B 18.86
Elekta AB (EKTAY) Sweden $2.693B 18.47
PROCEPT BioRobotics (PRCT) United States $2.584B 0.00
Integra LifeSciences Holdings (IART) United States $2.578B 10.58
Inari Medical (NARI) United States $2.364B 407.80
Nihon Kohden (NHNKY) Japan $2.359B 19.95
Tandem Diabetes Care (TNDM) United States $2.163B 0.00
RxSight (RXST) United States $2.037B 0.00
Alphatec Holdings (ATEC) United States $1.835B 0.00
Veracyte (VCYT) United States $1.519B 0.00
OPKO Health (OPK) United States $0.857B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.855B 15.82
Paragon 28 (FNA) United States $0.850B 0.00
Pacific Biosciences Of California (PACB) United States $0.849B 0.00
Artivion (AORT) United States $0.843B 97.43
OrthoPediatrics (KIDS) United States $0.740B 0.00
Treace Medical Concepts (TMCI) United States $0.734B 0.00
Silk Road Medical (SILK) United States $0.713B 0.00
SiBone (SIBN) United States $0.615B 0.00
Mesa Laboratories (MLAB) United States $0.566B 19.23
IRadimed (IRMD) United States $0.523B 30.36
ORTHOFIX MEDICAL INC (OFIX) United States $0.498B 0.00
Nevro (NVRO) United States $0.482B 0.00
Pulse Biosciences (PLSE) United States $0.399B 0.00
CVRx (CVRX) United States $0.361B 0.00
NeuroPace (NPCE) United States $0.355B 0.00
Tactile Systems Technology (TCMD) United States $0.351B 11.82
AxoGen (AXGN) United States $0.315B 0.00
Sight Sciences (SGHT) United States $0.288B 0.00
EDAP TMS S.A (EDAP) France $0.281B 0.00
AngioDynamics (ANGO) United States $0.255B 0.00
Accuray (ARAY) United States $0.226B 0.00
Atossa Genetics (ATOS) United States $0.208B 0.00
908 Devices (MASS) United States $0.200B 0.00
Alpha Tau Medical (DRTS) Israel $0.196B 0.00
Semler Scientific (SMLR) United States $0.194B 10.47
Inogen (INGN) United States $0.172B 0.00
ClearPoint Neuro (CLPT) United States $0.157B 0.00
Neuronetics (STIM) United States $0.129B 0.00
Delcath Systems (DCTH) United States $0.122B 0.00
Yubo Biotech (YBGJ) China $0.112B 0.00
Envoy Medical (COCH) United States $0.099B 0.00
Monogram Orthopaedics (MGRM) United States $0.098B 0.00
KORU Medical Systems (KRMD) United States $0.095B 0.00
Spectral Diagnostics (EDTXF) Canada $0.090B 0.00
Hyperfine (HYPR) United States $0.072B 0.00
EnVVeno Medical (NVNO) United States $0.066B 0.00
SEP Acquisition (SEPA) United States $0.056B 0.00
Sensus Healthcare (SRTS) United States $0.055B 112.67
Vicarious Surgical (RBOT) United States $0.055B 0.00
InspireMD (NSPR) Israel $0.054B 0.00
Autonomix Medical (AMIX) United States $0.054B 0.00
ReWalk Robotics (LFWD) Israel $0.046B 0.00
Aspira Women's Health (AWH) United States $0.043B 0.00
Rapid Micro Biosystems (RPID) United States $0.040B 0.00
Lucid Diagnostics (LUCD) United States $0.039B 0.00
LENSAR (LNSR) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.036B 0.00
Pixie Dust Technologies (PXDT) Japan $0.036B 0.00
Spectral AI (MDAI) United States $0.035B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.026B 0.00
Ekso Bionics Holdings (EKSO) United States $0.025B 0.00
QT Imaging Holdings (QTI) United States $0.024B 0.00
Accelerate Diagnostics (AXDX) United States $0.019B 0.00
PAVmed (PAVM) United States $0.018B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Biosig Technologies (BSGM) United States $0.012B 0.00
Avinger (AVGR) United States $0.007B 0.00
Helius Medical Technologies (HSDT) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00